E Fund Management »

Bridgebio Pharma shares owned by E Fund Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 220 74.26

More positions owned by E Fund Management

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
PDD Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
Apple (AAPL)
Yum China Holdings (YUMC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Newmont Mining Corporation (NEM)
Broadcom (AVGO)
H World Group Sponsored Ads (HTHT)
Meta Platforms Cl A (META)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for E Fund Management

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma